EUA
WANTAI SARS-CoV-2 Ab ELISA
FDA Emergency Use Authorization · Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. · Aug 5, 2020
Key facts
| Product | WANTAI SARS-CoV-2 Ab ELISA |
|---|---|
| Company | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. |
| Product type | Total Antibody, ELISA |
| Date | Aug 5, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: